Formic Acid

Formic Acid

SCHEMBL734324

O=C[O-].O=C[O-].O=C[O-].O=C[O-].[Ru+4]

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL11292741 0.94
Formic Acid SCHEMBL4302038 0.93 ALDH1A1 (0.38) ALDH1A1TSHR
Formic Acid SCHEMBL29897145 0.88 TSHR (0.36) TSHR
Formic Acid SCHEMBL991677 0.86 ALDH1A1 (0.33) ALDH1A1TSHR
Formic Acid SCHEMBL21268119 0.86 ALDH1A1 (0.33) ALDH1A1TSHR
Formic Acid SCHEMBL7796505 0.86
Formic Acid SCHEMBL2354 0.86
Formic Acid SCHEMBL20636861 0.86
Formic Acid SCHEMBL43484 0.86
Formic Acid SCHEMBL337949 0.86 ALDH1A1 (0.33) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103657682-B A kind of Catalysts and its preparation method for octanol reduction amination synthesis octylame DALIAN BIO-CHEM CO., LTD. (CN) 2015-12-30 CN claimed
CN-103657682-A Catalyst for synthesizing octylamine by carrying out reductive amination on octanol and preparation method thereof DALIAN BIO CHEM SHARE CO LTD 2014-03-26 CN claimed
US-8138095-B2 Method of substrate treatment, process for producing semiconductor device, substrate treating apparatus, and recording medium TOKYO ELECTRON LIMITED (JP) 2012-03-20 US claimed
US-5135901-A A catalyst composition comprising rhodium, ruthenium,and a promoter EASTMAN CHEMICAL COMPANY (US) 1992-08-04 US claimed
US-5043480-A Difunctional products from ethylene oxide and synthesis gas EASTMAN KODAK COMPANY (US) 1991-08-27 US claimed
US-4973741-A RHODIUM-RUTHENIUM CATALYST, GROUP 5A PROMOTER, CARBONYLATION, HYDROFORMYLATION EASTMAN KODAK COMPANY (US) 1990-11-27 US claimed
US-4144399-A OSMIUM OR RUTHENIUM-CONTAINING CATALYST ATLANTIC RICHFIELD COMPANY (US) 1979-03-13 US claimed
JP-60104024-A None JP disclosed
JP-59184141-A None JP disclosed
CN-121974955-A CO2Ruthenium catalyst for preparing formic acid and dehydrogenation of formic acid, and preparation method and application thereof 陕西氢能研究院有限公司 2026-05-05 CN disclosed
US-20250368676-A1 PROCESS FOR PREPARING NAMODENOSON ACCELLIENT PARTNERS LLC 2025-12-04 US disclosed
CN-120136691-A Polyester plastic and CO2Co-conversion formate-making process 北京大学 2025-06-13 CN disclosed
CN-119080806-A Metal organic complex, preparation method and application thereof, carbon dioxide-based polyurethane and preparation method and application thereof 中国科学院兰州化学物理研究所 2024-12-06 CN disclosed
US-5043480-A Difunctional products from ethylene oxide and synthesis gas EASTMAN KODAK COMPANY (US) 1991-08-27 US disclosed
US-4973741-A RHODIUM-RUTHENIUM CATALYST, GROUP 5A PROMOTER, CARBONYLATION, HYDROFORMYLATION EASTMAN KODAK COMPANY (US) 1990-11-27 US disclosed
JP-S60104024-A PRODUCTION OF OXYGEN-CONTAINING COMPOUND AGENCY OF IND SCIENCE & TECHNOL 1985-06-08 JP disclosed
JP-S59184141-A PRODUCTION OF ETHYLENE GLYCOL AGENCY OF IND SCIENCE & TECHNOL 1984-10-19 JP disclosed
US-4460709-A Process for producing oxygen-containing organic compounds AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) 1984-07-17 US disclosed
US-4144399-A OSMIUM OR RUTHENIUM-CONTAINING CATALYST ATLANTIC RICHFIELD COMPANY (US) 1979-03-13 US disclosed
US-3997578-A Oxidation of alcohols to carboxylic acids with ruthenium catalysts and peracid oxidizing agents ATLANTIC RICHFIELD COMPANY (US) 1976-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250368676-A1 PROCESS FOR PREPARING NAMODENOSON NAMPT, NQO1, AMPD1 ALDH1A1 331/4885TSHR 2539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.